*(Class "A" shares carry a maximum 5.50% front-end load)
Performance expenses and fees for these other share
classes will vary. The AMIDEX35 Israel Mutual Fund charges a 2% redemption fee
for "no-load" shares redeemed with 365 days of purchase. Past performance does not guarantee
future results. Investment reurn and principal value will fluctuate so that shares when redeemed
may be worth more or less than the original cost.
The AMIDEX35 Israel Mutual Fund is not diversified and is composed of only 35 Israeli companies. All
investments are inherently subject to market risk. The relatively limited
liquidity of some of the equities in the portfolio may affect the Funds'
ability to acquire desired positions quickly or unable to dispose of
securities at a desirable price and time. The Fund also invests in foreign
country securities which may involve economic, political and currency
risks. These factors may adversely affect the value of your
investment. The fund has other classes of shares.
The AMIDEX Cancer Innovations & Healthcare Fund is not diversified. A fund with high industry
concentration could entail
greater risk than a fund with more diversified holdings. All companies
are identified as belonging to the Healthcare Sector of the market. This sector may be
riskier than other market sectors. For instance, market conditions,
interest rates, or economic and regulatory developments can significantly affect an
issuer, an industry or even a group of related industries, more adversely than other
securities in the market as a whole. Investing in small sized companies involve greater
risk than is customarily associated with investments in larger more established companies
due to their lack of experience, cash reserve and lack of management depth.
|
